190 related articles for article (PubMed ID: 23818260)
1. Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function.
Oeste CL; Pérez-Sala D
Mass Spectrom Rev; 2014; 33(2):110-25. PubMed ID: 23818260
[TBL] [Abstract][Full Text] [Related]
2. Proteomic studies on protein modification by cyclopentenone prostaglandins: expanding our view on electrophile actions.
Garzón B; Oeste CL; Díez-Dacal B; Pérez-Sala D
J Proteomics; 2011 Oct; 74(11):2243-63. PubMed ID: 21459170
[TBL] [Abstract][Full Text] [Related]
3. Prostanoids with cyclopentenone structure as tools for the characterization of electrophilic lipid-protein interactomes.
Stamatakis K; Pérez-Sala D
Ann N Y Acad Sci; 2006 Dec; 1091():548-70. PubMed ID: 17341644
[TBL] [Abstract][Full Text] [Related]
4. Electrophilic prostaglandins: identification of protein targets and opportunities for drug discovery.
Pérez-Sala D
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S8. PubMed ID: 26461419
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory prostanoids: focus on the interactions between electrophile signaling and resolution of inflammation.
Díez-Dacal B; Pérez-Sala D
ScientificWorldJournal; 2010 Apr; 10():655-75. PubMed ID: 20419278
[TBL] [Abstract][Full Text] [Related]
6. Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
Gharbi S; Garzón B; Gayarre J; Timms J; Pérez-Sala D
J Mass Spectrom; 2007 Nov; 42(11):1474-84. PubMed ID: 17960581
[TBL] [Abstract][Full Text] [Related]
7. Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms?
Domingues RM; Domingues P; Melo T; Pérez-Sala D; Reis A; Spickett CM
J Proteomics; 2013 Oct; 92():110-31. PubMed ID: 23770299
[TBL] [Abstract][Full Text] [Related]
8. The C-terminus of H-Ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways.
Oeste CL; Díez-Dacal B; Bray F; García de Lacoba M; de la Torre BG; Andreu D; Ruiz-Sánchez AJ; Pérez-Inestrosa E; García-Domínguez CA; Rojas JM; Pérez-Sala D
PLoS One; 2011 Jan; 6(1):e15866. PubMed ID: 21253588
[TBL] [Abstract][Full Text] [Related]
9. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
Renedo M; Gayarre J; García-Domínguez CA; Pérez-Rodríguez A; Prieto A; Cañada FJ; Rojas JM; Pérez-Sala D
Biochemistry; 2007 Jun; 46(22):6607-16. PubMed ID: 17489560
[TBL] [Abstract][Full Text] [Related]
10. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.
Levonen AL; Landar A; Ramachandran A; Ceaser EK; Dickinson DA; Zanoni G; Morrow JD; Darley-Usmar VM
Biochem J; 2004 Mar; 378(Pt 2):373-82. PubMed ID: 14616092
[TBL] [Abstract][Full Text] [Related]
11. Protein disulfide isomerase as a novel target for cyclopentenone prostaglandins: implications for hypoxic ischemic injury.
Liu H; Chen J; Li W; Rose ME; Shinde SN; Balasubramani M; Uechi GT; Mutus B; Graham SH; Hickey RW
FEBS J; 2015 May; 282(10):2045-59. PubMed ID: 25754985
[TBL] [Abstract][Full Text] [Related]
12. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification.
Garzón B; Gayarre J; Gharbi S; Díez-Dacal B; Sánchez-Gómez FJ; Timms JF; Pérez-Sala D
Chem Biol Interact; 2010 Jan; 183(1):212-21. PubMed ID: 19800325
[TBL] [Abstract][Full Text] [Related]
13. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
Nair S; Li W; Kong AN
Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
[TBL] [Abstract][Full Text] [Related]
14. Nitric Oxide and Electrophilic Cyclopentenone Prostaglandins in Redox signaling, Regulation of Cytoskeleton Dynamics and Intercellular Communication.
Bago Á; Íñiguez MA; Serrador JM
Front Cell Dev Biol; 2021; 9():673973. PubMed ID: 34026763
[TBL] [Abstract][Full Text] [Related]
15. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.
Gayarre J; Stamatakis K; Renedo M; Pérez-Sala D
FEBS Lett; 2005 Oct; 579(25):5803-8. PubMed ID: 16223487
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry approaches for the redox characterization of protein cysteine residues the case of the transcription factor Pax-8.
Scaloni A; Tell G
Methods Enzymol; 2010; 473():227-50. PubMed ID: 20513481
[TBL] [Abstract][Full Text] [Related]
17. Chemical 'omics' approaches for understanding protein cysteine oxidation in biology.
Leonard SE; Carroll KS
Curr Opin Chem Biol; 2011 Feb; 15(1):88-102. PubMed ID: 21130680
[TBL] [Abstract][Full Text] [Related]
18. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
Ishii T; Uchida K
Chem Res Toxicol; 2004 Oct; 17(10):1313-22. PubMed ID: 15487891
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
[TBL] [Abstract][Full Text] [Related]
20. Proteomics approaches to study the redox state of cysteine-containing proteins.
Camerini S; Polci ML; Bachi A
Ann Ist Super Sanita; 2005; 41(4):451-7. PubMed ID: 16569913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
